Skip to content
When it comes to science and biotech, the gender gap between men and women still persists. The UNESCO Science Report Towards 2030 in 2015 […]
Women’s History Month: 12 women in science and biotech to know Read More »
Sickle cell disease (SCD) patients were given new hope in late 2023 when the Food and Drug Administration (FDA) approved two novel treatments. One
Could CRISPR be the answer to sickle cell disease? Read More »
As scientists and leading biotech companies are scrambling to achieve life-changing breakthroughs and treatments, sickle cell disease (SCD) is on the cusp of a
Sickle cell disease marks a few milestones, but more needs to be done Read More »
Bio.News recently caught up with Dr. Debbie Yaver, Chief Scientific Officer (CSO) of Nature’s Fynd. Nature’s Fynd is a Chicago, Illinois-based food tech company
Dr. Debbie Yaver: inaugural BIO Rosalind Franklin Award winner Read More »
Clinical trial diversity used to be seen “as kind of a ‘nice to have,’” said Gary A. Puckrein, Ph.D., President and CEO of the
Black History Month reminds us of the dire need for clinical trial diversity Read More »
Breakthroughs in biotech involve collaboration at every level. While entrepreneurial innovation is often the most visible, it’s policymaking and government leadership that lays the
Black History Month: the policymakers & government leaders advancing biotech Read More »
February marks Black History Month, an important annual reminder of the contributions Black and African Americans have made to the progress of biotechnology, and
Black History Month pioneers: advancing science and representation Read More »
In October 2023, Genentech announced results from the first-ever clinical trial designed exclusively to enhance the knowledge base supporting the Black and Hispanic population
Genentech Q&A: Improving MS treatment and clinical trial diversity Read More »
Clinical trial diversity has been one of the most pressing needs in the healthcare industry for decades. For this and many other reasons, the
BIO unveils updated resources to improve clinical trial diversity Read More »
Amgen Inc., an Advocate level sponsor of the 2023 BIO Patient & Health Advocacy Summit, provided their approval to share this previously published article
